Obesity drugs may soon see more insurance coverage, and Boston study to test new medication
Here’s some interesting news from the obesity drug front. First off, Aetna, one of the nation’s largest insurers, announced Wednesday that it was going to provide coverage for prescription obesity medications including Qsymia and Belviq. Many insurance companies have been dragging their feet on reimbursing for the drugs, which has led to a lag in sales. Also, Boston Medical Center researchers are now looking for overweight volunteers to enroll in a clinical trial to test an experimental obesity drug.